IBX 2.50% 3.9¢ imagion biosystems limited

Interesting, page-1179

  1. 864 Posts.
    lightbulb Created with Sketch. 74
    It seems to me the biggest threat to the prospects of the company is trial failure of some kind or competing technology. I recently saw the following article https://www.dailymail.co.uk/sciencetech/article-8435753/Finger-prick-blood-test-revolutionise-cancer-treatment.html. Could someone knowledgeable on the science comment on this, is this a competing technology and of concern to investors in IBX?
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.